NASDAQ
AC Immune S.A. (ACIU) has a current ratio of 1.02x as of Monday, May 25, 2026. This represents a 87.31% decrease compared to its 12-month average of 8.05x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.